NZ279238A - Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof - Google Patents

Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof

Info

Publication number
NZ279238A
NZ279238A NZ279238A NZ27923895A NZ279238A NZ 279238 A NZ279238 A NZ 279238A NZ 279238 A NZ279238 A NZ 279238A NZ 27923895 A NZ27923895 A NZ 27923895A NZ 279238 A NZ279238 A NZ 279238A
Authority
NZ
New Zealand
Prior art keywords
microgranules
prolonged
form according
release
galenic form
Prior art date
Application number
NZ279238A
Other languages
English (en)
Inventor
Gerard Leduc
Patrice Debregeas
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/fr
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of NZ279238A publication Critical patent/NZ279238A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ279238A 1994-01-14 1995-01-12 Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof NZ279238A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (fr) 1994-01-14 1994-01-14 Nouvelle forme galénique de dérivés de 5-nitro-imidazole efficace pour le traitement des parasitoses et des infections de l'ensemble du tractus gastro-intestinal.
PCT/FR1995/000039 WO1995019168A1 (fr) 1994-01-14 1995-01-12 Microgranules de derives de 5-nitro imidazole

Publications (1)

Publication Number Publication Date
NZ279238A true NZ279238A (en) 1998-03-25

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ279238A NZ279238A (en) 1994-01-14 1995-01-12 Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof

Country Status (19)

Country Link
JP (1) JPH09507499A (da)
KR (1) KR100320140B1 (da)
CN (1) CN1088357C (da)
AT (1) ATE187068T1 (da)
AU (1) AU705570B2 (da)
BR (1) BR9506507A (da)
CZ (1) CZ286080B6 (da)
DE (1) DE69513632T2 (da)
DK (1) DK0739201T3 (da)
ES (1) ES2139883T3 (da)
MA (1) MA23429A1 (da)
MX (1) MX9602772A (da)
NZ (1) NZ279238A (da)
OA (1) OA10583A (da)
PL (1) PL178424B1 (da)
PT (1) PT739201E (da)
RU (1) RU2152212C1 (da)
SK (1) SK282066B6 (da)
UA (1) UA28031C2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (ja) * 2001-10-17 2009-09-16 武田薬品工業株式会社 酸に不安定な薬物の高含量顆粒
US10335390B2 (en) 2014-09-05 2019-07-02 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
EP0528971B1 (en) * 1990-05-14 1999-09-01 JERNBERG, Gary R. Surgical implant and method incorporating chemotherapeutic agents

Also Published As

Publication number Publication date
AU705570B2 (en) 1999-05-27
CN1138826A (zh) 1996-12-25
CZ286080B6 (cs) 2000-01-12
MX9602772A (es) 1997-05-31
DE69513632T2 (de) 2000-04-06
SK91496A3 (en) 1996-12-04
SK282066B6 (sk) 2001-10-08
BR9506507A (pt) 1997-09-09
CN1088357C (zh) 2002-07-31
ES2139883T3 (es) 2000-02-16
RU2152212C1 (ru) 2000-07-10
PL315530A1 (en) 1996-11-12
PL178424B1 (pl) 2000-04-28
OA10583A (en) 2002-07-10
UA28031C2 (uk) 2000-10-16
DK0739201T3 (da) 2000-05-01
KR100320140B1 (ko) 2002-07-02
ATE187068T1 (de) 1999-12-15
DE69513632D1 (de) 2000-01-05
AU1580395A (en) 1995-08-01
PT739201E (pt) 2000-05-31
MA23429A1 (fr) 1995-10-01
CZ205596A3 (en) 1996-10-16
JPH09507499A (ja) 1997-07-29

Similar Documents

Publication Publication Date Title
RU2681315C2 (ru) Лекарственные формы для пероральной доставки адсорбентов в кишечник
TW576743B (en) Extended release formulations of erythromycin derivatives
CA2041400C (en) Preparation of a medicament
AU774099B2 (en) Controlled release compositions comprising nimesulide
JP3725542B2 (ja) ピコサルフェート剤形
BRPI0608853B1 (pt) composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes
TW201041607A (en) Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
JP2000514051A (ja) ベンズイミダゾール誘導体を活性成分とする経口投与用の安定な薬剤形およびその製造方法
JP2002080398A (ja) ｐＨに依存する多相的な放出を伴う経口用の固体の薬学的組成物
KR20050005437A (ko) 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
CN105163743A (zh) 用于治疗幽门螺杆菌的药物组合物
JP2009543791A (ja) 即放性形態および徐放性形態のトラマドールを有するマルチパーティキュレート処方物
US20060159758A1 (en) Coating composition for taste masking coating and methods for their application and use
CH675537A5 (da)
US5549911A (en) Galenic form of 5-nitromidazole derivatives which is effective for the treatment of parasitoses and infections of the entire gastrointestinal tract
JPS63258809A (ja) 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
CZ20032488A3 (cs) Gastroirezistentní soli ketokyselin a aminikyselin a jejich použití pro přípravu léků
NZ279238A (en) Microgranules containing 5-nitro-imidazole derivatives, mixtures of gastroresistant and prolonged-release microgranules, and medicaments thereof
CA2180837C (fr) Microgranules de derives de 5-nitro imidazole
US20230398102A1 (en) Rifaximin liquid formulations for use inthe treatment of sickle cell disease
JPS61137813A (ja) 持続性セフラジン製剤
WO2023089553A1 (en) Controlled release formulations of flavoxate and process for preparation thereof
AU2003270948B2 (en) Extended Release Formulations of Erythromycin Derivatives
MC MK et al. preparation thereof
JPWO2003075918A1 (ja) 塩酸ピルジカイニド含有錠剤（湿式）

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)